Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN)
JAMA. 2012 307 (16): 1717-26

PMID: 22447880 · PMCID: PMC3600947 · DOI:10.1001/jama.2012.418

MeSH Terms (17)

Angina Pectoris Bone Marrow Transplantation Coronary Artery Disease Coronary Circulation Double-Blind Method Female Heart Failure Humans Injections Male Middle Aged Myocardial Ischemia Oxygen Consumption Tomography, Emission-Computed, Single-Photon Transplantation, Autologous Treatment Outcome Ventricular Dysfunction, Left

Connections (1)

This publication is referenced by other Labnodes entities: